Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. - Wikidata - awgldk - TriplyDB

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.

http://www.wikidata.org/entity/Q33382390

about

Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan.Systemic lupus erythematosus presenting as thrombotic thrombocytopenia purpura: how close is close enough?Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus.Thrombotic thrombocytopenic purpura associated with mixed connective tissue disease: a case report.Systemic sclerosis with thrombotic thrombocytopenia purpura and malignant hypertension.Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus Acquired thrombotic thrombocytopenic purpura in children: a single institution experience.Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011.Cryosupernatant and Immunosuppression as Effective Alternative Therapies for TTP in Three Pediatric SLE Patients.Thrombotic thrombocytopenic purpura as an initial presentation of systemic lupus erythematosus with acquired ADAMTS 13 antibody Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura.Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study Anemia in lupus nephritis; etiological profile Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Thrombotic thrombocytopenic purpura and deep vein thrombosis as the presenting manifestations of systemic lupus erythematosus: A case report and review of literature.TMA secondary to SLE: rituximab improves overall but not renal survival.ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status?Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China.A 26-year-old white man with a systemic lupus erythematosus flare and acute multiorgan ischemia: Vasculitis or thrombosis?Thrombotic microangiopathies Thrombotic thrombocytopenic purpura as the first presentation in systemic lupus erythematosus

P2860

Q28067041-BA6C82ED-7ACA-4961-874B-2BAA5C0523AF Q33393240-1833A894-EB4C-423B-AD36-4782A5A0358B Q33395602-88491AC5-60F9-4E05-A199-8FD45B0A1472 Q33396421-590D2937-024A-414A-A15B-AE1E51E3B367 Q33397193-5085E4C5-2C0E-4E35-8D55-58CF51871A1F Q33402720-FEE8265D-B956-4DC6-BAEF-7D59B9619066 Q33403301-A7028339-6EE1-4FBC-93CA-6192E4F8FBB3 Q33404950-AE91E6BD-2D83-41CE-A849-09B10347C54F Q33409869-CC2E440F-FF96-4366-8EE2-E0C34D595171 Q33418313-AE7B9E79-8126-43C4-8564-ED27E35C840D Q33420591-FEFBA420-4C27-4E25-817A-1D344D17FFD2 Q33426998-9D61E797-E26D-4070-BDDC-8E549F8DFAB6 Q33432006-8EEC8FAC-06F4-4419-B222-2C82A2EDE396 Q34385879-758B7D57-B68D-46EF-9E25-9C22CD107B94 Q37954539-D4C37EA2-38F2-4BCB-9CAB-2CD7E2EE7797 Q37978860-023FCE77-3C7C-4F67-BBC2-3820F6BB4190 Q38601065-0805C9F1-DB1F-4750-B445-677F6971D875 Q43866756-85DD9EF0-F736-412C-B101-80B4435C94DA Q52759733-7DB2EDB0-689C-4E06-8FF7-5515F7778726 Q53245134-228FBB5B-D43B-470F-A00B-93D8E99673C2 Q58690782-1D5C5BEC-5937-4A93-9FAE-68257CD6BC8F Q58779824-BFE72181-A599-4AE1-835D-2ADB472DE7A2

P2860

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.

http://www.wikidata.org/entity/Q33382390

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Thrombotic thrombocytopenic pu ...... utcome: a single centre study.

@ast

Thrombotic thrombocytopenic pu ...... utcome: a single centre study.

@en

type

label

Thrombotic thrombocytopenic pu ...... utcome: a single centre study.

@ast

Thrombotic thrombocytopenic pu ...... utcome: a single centre study.

@en

prefLabel

Thrombotic thrombocytopenic pu ...... utcome: a single centre study.

@ast

Thrombotic thrombocytopenic pu ...... utcome: a single centre study.

@en

P1433

Q33382390-138DF68A-3D06-45AB-9557-CFA49D8E576E

P1476

Q33382390-717D8059-13CC-4A3E-937C-17EBF9730CDF

P2093

Q33382390-7DA43260-0DEA-42D3-9FF5-BF44795FD7E7

Q33382390-86EEFC44-63D5-4144-902F-E51E800E90BA

Q33382390-8DC33BDA-276D-4ECE-9EE8-6D53D3A1588E

Q33382390-A2AAE0A3-4622-49C1-A8F0-20A655E3E800

Q33382390-E4721E94-991C-4657-8A34-6994BAA12F69

P2860

Q33382390-0802A49B-8FA6-4C21-9F57-CCDAA9BE275D

Q33382390-08F2EB3A-AAB4-4FBC-A380-244101C49662

Q33382390-0A354C8A-6185-4ACE-9356-C9701D4874BB

Q33382390-0E6C45B5-410A-47C2-8C7A-C0B6B562EA8B

Q33382390-0F504581-D4DF-4B05-9515-8AA841903136

Q33382390-0FCAE58A-0C74-4301-AE47-BBFCCF793035

Q33382390-1CC2A30C-7E36-4C40-A239-37914324B30E

Q33382390-1E939CC4-C310-49C0-B769-BECC083F8D49

Q33382390-30DA57F4-CA46-477C-8F4B-B1585572F675

Q33382390-32D7127D-720E-4D72-84B2-D995C6750948

P304

Q33382390-07F4E0D4-9440-45CE-88CC-7BCC67A5BAE0

P31

Q33382390-6E463D63-8D54-45ED-9EAA-17B1C4625CAB

P356

Q33382390-8D808191-F94D-4008-ACB6-5CA84C25770F

P433

Q33382390-DEF47A24-B771-404E-BB89-6E39CE5ABA07

P478

Q33382390-68CF86E9-8589-40CD-B33D-28B1451F5E2D

P577

Q33382390-56C056FD-EF1E-46E5-BD4B-B83AE1EFBAF4

P698

Q33382390-D19FCBAF-2CAD-4B86-835D-69434B2DF665

P921

Q33382390-E8841987-8A6E-4B03-A8AA-BC0E75C8E8DE

P356

0961203308094360

P1433

P1476

Thrombotic thrombocytopenic pu ...... utcome: a single centre study.

@en

P2093

C S Cho

http://www.w3.org/2001/XMLSchema#string

H Y Kim

http://www.w3.org/2001/XMLSchema#string

J H Ju

http://www.w3.org/2001/XMLSchema#string

S H Park

http://www.w3.org/2001/XMLSchema#string

S K Kwok

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

The 1982 revised criteria for the classification of systemic lupus erythematosus

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs.

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.

Molecular mechanisms in thrombotic thrombocytopenic purpura.

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.

P304

16-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203308094360

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19074164

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia